They are investigating a pan-PPAR agonist in metabolic syndrome that, due to its different mechanisms, can reduce the number of drugs consumed and adherence problems.
Incliva researchers Carlos Villarroel-Vicente, Patrice Marques, Laura Piqueras, María Jesús Sanz, Nuria Cabedo, Laura Vila, Ainhoa García and Álvaro Bernabeu. Photo: INCLIVA
Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.
